Home
Search results for "hiv"
The thioacetate-ω(γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent by Roger Badia & Judith Grau & Eva Riveira-Muñoz & Ester Ballana & Giuseppe Giannini & José A. Esté
pdf | | 2015-09-10 | Author:Roger Badia & Judith Grau & Eva Riveira-Muñoz & Ester Ballana & Giuseppe Giannini & José A. Esté

( Category: other February 25,2021 )
Structural and pharmacological evaluation of a novel non-nucleoside reverse transcriptase inhibitor as a promising long acting nanoformulation for treating HIV by unknow
pdf | | 2019-05-30 | Author:unknow

( Category: other February 25,2021 )
The new and less toxic protease inhibitor saquinavir–NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir by unknow
pdf | | 2011-08-18 | Author:unknow

( Category: other February 25,2021 )
Assessment of topical microbicides to prevent HIV-1 transmission: Concepts, testing, lessons learned by David R. Friend & Patrick F. Kiser
pdf | | 2013-08-30 | Author:David R. Friend & Patrick F. Kiser

( Category: other February 25,2021 )
Spray drying tenofovir loaded mucoadhesive and pH-sensitive microspheres intended for HIV prevention by Tao Zhang & Chi Zhang & Vivek Agrahari & James B. Murowchick & Nathan A. Oyler & Bi-Botti C. Youan
pdf | | 2013-03-19 | Author:Tao Zhang & Chi Zhang & Vivek Agrahari & James B. Murowchick & Nathan A. Oyler & Bi-Botti C. Youan

( Category: other February 25,2021 )
HIV-coinfection leads to a modest increase in plasma HCV-RNA load in patients with chronic HCV infection by unknow
pdf | | 2012-08-17 | Author:unknow

( Category: other February 25,2021 )
A new chimeric protein represses HIV-1 LTR-mediated expression by DNA methylase by unknow
pdf | | 2013-05-13 | Author:unknow

( Category: other February 25,2021 )
Heme arginate potentiates latent HIV-1 reactivation while inhibiting the acute infection by Prakash Shankaran & Lenka Vlkova & Jana Liskova & Zora Melkova
pdf | | 2011-11-11 | Author:Prakash Shankaran & Lenka Vlkova & Jana Liskova & Zora Melkova

( Category: other February 25,2021 )
A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid by Da-Wei Zhang
pdf | | | Author:Da-Wei Zhang

( Category: other February 25,2021 )
Synergistic in vitro anti-HIV type 1 activity of tenofovir with carbohydrate-binding agents (CBAs) by unknow
pdf | | 2011-05-18 | Author:unknow

( Category: other February 25,2021 )
The rare HIV-1 gp41 mutations 43T and 50V elevate enfuvirtide resistance levels of common enfuvirtide resistance mutations that did not impact susceptibility to sifuvirtide by unknow
pdf | | 2010-04-05 | Author:unknow

( Category: other February 25,2021 )
Insights from host genomics into HIV infection and disease: Identification of host targets for drug development by Ester Ballana & José A. Esté
pdf | | 2013-10-23 | Author:Ester Ballana & José A. Esté

( Category: other February 25,2021 )
Transmission of HIV drug resistance and non-B subtype distribution in the Spanish cohort of antiretroviral treatment naïve HIV-infected individuals (CoRIS) by unknow
pdf | | 2011-07-06 | Author:unknow

( Category: other February 25,2021 )
Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus by Enzo Tramontano & Angela Corona & Luis Menéndez-Arias
pdf | | 2019-10-15 | Author:Enzo Tramontano & Angela Corona & Luis Menéndez-Arias

( Category: other February 25,2021 )
Resistance associated mutations to dolutegravir (SGSK1349572) in HIV-infected patients – Impact of HIV subtypes and prior raltegravir experience by unknow
pdf | | 2011-05-18 | Author:unknow

( Category: other February 25,2021 )

First Prev [71] [72] [73] [74] 75 [76] [77] [78] [79] [80] [81] Next Last